© 1995 Oxford University Press
RESEARCH-ARTICLE |
On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1
Abteilung Humangenetik, Universität Ulm D-89081 Ulm 1Institut für Medizinische Genetik, Universitätsklinikum Charité D-10089 Berlin, Germany
*To whom correspondence should be addressed
Received March 6, 1995; Revised April 24, 1995; Accepted April 24, 1995
The autosomal dominantly inherited disease neurofibromatosis type 1 (NF1) is caused by mutations of a large gene comprising 59 exons, which code for a protein with 2818 amino acids called neurofibromin. Employing an expressed polymorphic site in exon 5 of the neurofibromin gene, the expression of its alleles was analysed quantitatively by scanning radioactive RT-PCR fragments of this exon prepared from the RNA of fibroblast cell cultures from 15 NF1 patients and of white blood cells from one NF1 patient. Thirteen of the RNA preparations yielded unequal amounts of the allelic messages. The deviations of the expression ratios (A2: A1) from 1.0 ranged from 0.9 to +25.8. The allelic messages were equally represented in the RNA preparations from five informative healthy donors. Apart from fibroblasts this phenomenon could also be detected in keratinocytes, melanocytes from normally pigmented skin and melanocytes from a café-au-lait spot of one patient. Only one of three patients affected by stop mutations exhibited unequal allelic expression. When nuclear RNA from 10 of the 13 patients was examined, equal amounts of the primary transcripts were found (average ratio A2/A1: 1.08 ± 0.07 S.E.M.), indicating that unequal expression on the level of mRNA was not caused by mutations affecting transcriptional regulation. The ratio of the amount of neurofibromin to that of p120 GAP did not seem to be correlated with the extent of unequal allelic expression.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. M. Siddique, C. Balram, L. Fiszer-Maliszewska, A. Aggarwal, A. Tan, P. Tan, K. C. Soo, and K. Sabapathy Evidence for Selective Expression of the p53 Codon 72 Polymorphs: Implications in Cancer Development Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2245 - 2252. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Ars, H Kruyer, M Morell, E Pros, E Serra, A Ravella, X Estivill, and C Lazaro Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients J. Med. Genet., June 1, 2003; 40(6): e82 - 82. [Full Text] [PDF] |
||||
![]() |
H. H. Schiffer, G. T. Swanson, E. Masliah, and S. F. Heinemann Unequal Expression of Allelic Kainate Receptor GluR7 mRNAs in Human Brains J. Neurosci., December 15, 2000; 20(24): 9025 - 9033. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ars, E. Serra, J. Garcia, H. Kruyer, A. Gaona, C. Lazaro, and X. Estivill Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1 Hum. Mol. Genet., January 22, 2000; 9(2): 237 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Martinez, H H Breidenbach, and R Cawthon Long RT-PCR of the entire 8.5-kb NF1 open reading frame and mutation detection on agarose gels. Genome Res., January 1, 1996; 6(1): 58 - 66. [Abstract] [PDF] |
||||




